“Let food be thy medicine and medicine be thy food” Hippocrates, father of medicine
Establishing partnerships with world leaders in Medical Cannabis Research
We are dedicated to bring the best nature has to offer
Shaping an Australian focused future in cannabinoid research
Welcome to Cann Global Limited
Cann Global Limited is a driving force in the medical Cannabis industry. Our strength comes from our team’s core competencies and expertise and our solid and strategic partnerships with experts in Australia, Israel and Canada. We believe in building a stronger industry together. We are working under the provision of legislations to ensure that the future in Medical Cannabis and Natural Foods will allow medical practitioners, patients and consumers to gain access to the right information, as well as the safest, most effective and sustainable products. Part of our work is to keep researching and educating. We are part of a worldwide movement, the return to Nature. This movement is more than just a phenomenon, it is a necessity. At Cann Global Limited, we are committed to leading a movement, not just a business.
5th May: Cann Global posts its Replacement March Quarterly Activities and Cash-Flow Report. The company is pleased to provide a COVID-19 & Mining Update.
19th March: Cann Global has entered into agreements for the refinancing of the convertible notes and a further $862,000 investment with L1 Capital Global and Obsidian Global GP, LLC
2nd March: Cann Global was pleased to report its Dec 2019 Half Yearly Operational Report and Financials
17th February: Cann Global has
agreed to place 34 million new fully paid ordinary shares (New Shares) to institutional
and sophisticated investors led by New York-based Sea Otter Global (Sea Otter)
23rd January: T12 to supply new product range to Costco Australia ~ EPCO Foods Vietnam increases supply request by 50%